Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on the discrimination of durations: Evidence for the involvement of 5-HT2A but not 5-HT3 receptors

Behavioural Pharmacology

Volumn 16, Issue 1, 2005, Pages 43-51

  Asgari, K ^a   Body, S ^a   Rickard, J F ^b   Zhang, Z ^a   Fone, K C F ^a   Bradshaw, C M ^a   Szabadi, E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Medical School ^*

Author keywords

5 HT2a receptors; Ketanserin; m CPBG; MDL 72222; Quipazine; Rat; Temporal discrimination; Timing

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; BEMESETRON; KETANSERIN; QUIPAZINE; RECEPTOR SUBTYPE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG SELECTIVITY; FEMALE; NONHUMAN; PSYCHOPHYSIOLOGY; RAT; REINFORCEMENT; STATISTICAL MODEL; STIMULUS RESPONSE; TIME PERCEPTION;

ANIMALS; BIGUANIDES; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; FEMALE; KETANSERIN; QUIPAZINE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TROPANES;

EID: 14844364374     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200502000-00005     Document Type: Article

References (34)

1. Al-Ruwaitea ASA, Al-Zahrani SSA, Ho M-Y, Bradshaw CM, Szabadi E (1997). 5-Hydroxytryptamine and interval timing. In: Bradshaw CM, Szabadi E (editors): Time and Behaviour: Psychological and Neurobehavioural Analyses. Amsterdam: Elsevier; pp. 517-570.
2. Al-Zharani SSA, Ho M-Y, Velazquez-Martinez DN, Lopez-Cabrera M, Bradshaw CM, Szabadi E (1996). Effect of the destruction of the 5-hydroxytryptaminergic pathways on behavioural timing and 'switching' in a free-operant psychophysical procedure. Psychopharmacology (Bert) 127:346-352.
3. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
4. 2 receptor subtypes: a family reunited? Trends Pharmacol Sci 16:105-110.
5. Body S, Chiang T-J, Mobini S, Ho M-Y, Bradshaw CM, Szabadi E (2001). Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure. Psychopharmacology (Berl) 158:305-313.
6. Body S, Chiang T-J, Mobini S, Ho M-Y, Bradshaw CM, Szabadi E (2002a). Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion. Pharmacol Biochem Behav 71:787-793.
7. Body S, Kheramin S, Mobini S, Velazquez-Martinez DN, Bradshaw CM, Szabadi E (2002b). Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT depleted rats. Behav Pharmacol 13:603-614.
8. 2 receptor agonist, DOI (2,5-dimethoxy-4- iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule. Behav Pharmacol 14:599-607.
9. 2A receptors. Psychopharmacology (Berl) 176: 154-165.
10. 2A receptors [Abstract]. J Psychopharmacol 18:A42.
11. 2 receptor. Mol Pharmacol 38:604.
12. Chiang T-J, Al-Ruwaitea ASA, Mobini S, Ho M-Y, Bradshaw CM, Szabadi E (2000). Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules. Psychopharmacology (Berl) 151:379-391.
13. 3 receptor antagonists. Pharmacol Toxicol 70:157-162.
14. Fozard JR (1984). MDL-72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Arch Pharmacol NS 326:36-44.
15. Gibbon J, Malpani C, Dale CL, Gallistel CR (1997). Toward a neurobiology of temporal cognition: advances and challenges. Curr Opin Neurobiol 7:170-184.
16. 3 serotonin receptors: results of a structure-affinity study. Eur J Pharmacol 168:387-392.
17. Grondin S (2001). From physical time to the first and second moments of psychological time. Psychol Bull 127:22-24.
18. 3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning. Psychopharmacology (Berl) 106:315-320.
19. 3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 264:1440-1449.
20. Ho M-Y, Al-Zahrani SSA, Al-Ruwaitea ASA, Bradshaw CM, Szabaid E (1998). 5-Hydroxytryptamine and impulse control: prospects for a behavioural analysis. J Psychopharmacol 12:68-78.
21. Ho M-Y, Velazquez-Martinez DN, Bradshaw CM, Szabadi E (2002). 5-Hydroxytryptamine and interval timing behaviour. Pharmacol Biochem Behav 71:773-785.
22. 1 recognition sites. J Recept Res 8:59-81.
23. Hoyer D, Hannon JP, Martin GR (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554.
24. Killeen P, Fetterman JG (1988). A behavioral theory of timing. Psychol Rev 95:274-295.
25. Killeen P, Fetterman JG, Bizo LA (1997). Time's causes. In: Bradshaw CM, Szabadi E (editors): Time and Behaviour: Psychological and Neurobehavioural Analyses. Amsterdam: Elsevier; pp. 79-131.
26. 3 receptor agonist. Eur J Pharmacol 182:193-197.
27. 2 receptors. Life Sciences 28:1015-1022.
28. Matell MS, Meek WH (2000). Neuropsychological mechanisms of interval timing behaviour. Bioessays 22:94-103.
29. 3 receptor antagonists in rats. Psychopharmacology (Berl) 121:488-493.
30. 3H]-GR65630 binding. Br J Pharmacol 102:919-925.
31. Stubbs DA (1976). Scaling of stimulus duration by pigeons. J Exp Anal Behav 26:15-25.
32. 2 serotonergic receptors. J Pharmacol Exp Ther 218:217-230.
33. Zeiler MD (1998). On sundials, springs and atoms. Behav Proc 44:89-99.
34. 1Dβ receptor subtypes. Eur J Pharmacol (Mol Pharmacol Sect) 291:9-15.